Samtidig indtagelse af 100 mg itraconazol, en CYP3A4- hæmmer, er også undersøgt hos frivillige raske personer og øgede repaglinidoptagelsen (AUC) 1, 4 gange.
Co-administration of 100 mg itraconazole, an inhibitor of CYP3A4, has also been studied in healthy volunteers, and increased the AUC by 1.4-fold.